NCT02093468View on ClinicalTrials.gov

Evaluation of MST-188 in Acute Lower Limb Ischemia

PHASE2TerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2016

Conditions
Acute Limb Ischemia
Interventions
DRUG

MST-188

DRUG

Saline

Trial Locations (4)

11219

Research Center, Brooklyn

33606

Research Center, Tampa

44106

Research Center, Cleveland

72205

Research Center, Little Rock

Sponsors
All Listed Sponsors
lead

Mast Therapeutics, Inc.

INDUSTRY

NCT02093468 - Evaluation of MST-188 in Acute Lower Limb Ischemia | Biotech Hunter | Biotech Hunter